Wednesday, May 08 2024
12:00 PM – 07:00 PM ET - Exhibit Hall
868: Efficient T-cell Activation and Expansion for CAR-T Therapy is Dependent on a Complex Interplay of the Starting Donor Population, Activation Antibodies and Expansion Platform
Matt Heidtman - Ph.D.
Bio-Techne
Disclosures: M. Heidtman: 1; Commercial Interest i.e. Company X; Bio-Techne. 1; What was received? i.e. Honorarium; Salary. 1; For what role? i.e. Speaker; Employment.
Related Abstract